Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Clin Trials. 2021 Nov 29;19(1):86–96. doi: 10.1177/17407745211046672

Table 6.

Covariate adjustment and missing data treatment (N=62)

Characteristic Frequency (%)

If covariates were used in the randomization, did primary outcome analysis adjust for those covariates? (N=38)
 Yes, for all relevant covariates 14 (36.8%)
 Yes, but not for all relevant covariates 4 (10.5%)
 No 18 (47.4%)
 Uncleara 2 (3.2%)

Does the trial have missing outcomes or attrition for the primary outcome?
 Yes 59 (95.2%)
 No 2 (3.2%)
 Unclear 1 (1.6%)

Method used to account for missing data in the primary analysis of the primary outcome (N=59)
 None 34 (57.6%)
 Regression adjustment for covariates stated to be associated with missingness 6 (9.7%)
 Single imputation 9 (14.5%)
 Multiple imputation 9 (14.5%)
 Otherb 1 (1.7%)

Method used to account for missing data in sensitivity analyses of the primary outcome (N=59)
 None 52 (88.1%)
 Regression adjustment for covariates stated to be associated with missingness 3 (5.1%)
 Single imputation 2 (3.4%)
 Multiple imputation 1 (1.7%)
 Otherc 1 (1.7%)

Any method used to account for missing data in primary or sensitivity analyses for the primary outcome?
 Yes 27 (45.8%)
 No 32 (54.2%)

Did the trial report a statistically significant effect for the primary outcome(s)?
 Yes 30 (48.4%)
 No 29 (46.8%)
 Mixed resultsd 3 (4.8%)
a

One trial presented both adjusted and unadjusted analyses without clearly stating the primary analysis; one trial used stratification but did not define the stratification variables

b

Primary outcome assessed in “modified intent to treat population” consisting only of those residents with available data at 8 months

c

Single imputation for primary analysis followed by complete case analysis as sensitivity analysis

d

One trial did not present results for the overall outcome score, but only for the individual components; one three-arm trial had two co-primary outcomes with mixed results; one trial had three co-primary outcomes with mixed results